Robert E Miller Insider Trading $OCLS Sonoma Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert E Miller.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert E Miller. Robert E Miller is in Sonoma Pharmaceuticals, Inc. ($OCLS) and Chief Financial Officer in Oculus Innovative Sciences, Inc. ($OCLS).
Robert E Miller in Sonoma Pharmaceuticals, Inc.
Trading Symbol: OCLSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert E Miller:
Holdings: 17,668 shares
Latest Transaction: Jan 15 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Robert E Miller in Sonoma Pharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 2.41 | 67,733 | 163,237 | 0 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 7.06 | 30,000 | 211,800 | 67,733 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 4.81 | 50,000 | 240,500 | 97,733 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 5.80 | 7,912 | 45,890 | 147,733 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 19.50 | 26,020 | 507,390 | 155,645 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 14.85 | 5,351 | 79,462 | 181,665 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 32.55 | 4,285 | 139,477 | 187,016 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 43.75 | 1,785 | 78,094 | 191,301 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 56.00 | 5,000 | 280,000 | 193,086 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 70.35 | 357 | 25,115 | 198,086 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 68.95 | 5,357 | 369,365 | 198,443 | ||
Jan 15 2019 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Option Exercise | H | 38.15 | 5,271 | 201,089 | 203,800 | ||
Jul 24 2018 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 2.41 | 67,733 | 163,237 | 209,071 | |
Mar 14 2018 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 4.10 | 1,200 | 4,920 | 18,868 | 17.7 K to 18.9 K (+6.79 %) |
Mar 14 2018 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 4.03 | 1,200 | 4,836 | 17,668 | 16.5 K to 17.7 K (+7.29 %) |
Mar 13 2018 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 4.03 | 1,200 | 4,836 | 16,468 | 15.3 K to 16.5 K (+7.86 %) |
Mar 13 2018 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 3.90 | 1,200 | 4,680 | 15,268 | 14.1 K to 15.3 K (+8.53 %) |
Nov 30 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 5.02 | 1,290 | 6,476 | 14,068 | 12.8 K to 14.1 K (+10.10 %) |
Nov 30 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 5.03 | 500 | 2,515 | 12,778 | 12.3 K to 12.8 K (+4.07 %) |
Nov 24 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 5.04 | 500 | 2,520 | 12,278 | 11.8 K to 12.3 K (+4.25 %) |
Nov 24 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 5.03 | 1,500 | 7,545 | 11,778 | 10.3 K to 11.8 K (+14.59 %) |
Aug 14 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 5.30 | 2,264 | 11,999 | 10,728 | 8.5 K to 10.7 K (+26.75 %) |
Jun 30 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Grant | A | 0.00 | 4,124 | 0 | 20,088 | 16 K to 20.1 K (+25.83 %) |
Apr 05 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 7.06 | 30,000 | 211,800 | 140,866 | |
Mar 13 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 7.14 | 250 | 1,785 | 8,464 | 8.2 K to 8.5 K (+3.04 %) |
Mar 13 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 6.96 | 250 | 1,740 | 8,214 | 8 K to 8.2 K (+3.14 %) |
Mar 13 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 6.97 | 250 | 1,743 | 7,964 | 7.7 K to 8 K (+3.24 %) |
Mar 09 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 6.97 | 750 | 5,228 | 7,714 | 7 K to 7.7 K (+10.77 %) |
Mar 09 2017 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 6.81 | 250 | 1,703 | 6,964 | 6.7 K to 7 K (+3.72 %) |
Dec 12 2016 | OCLS | Sonoma Pharmaceuti ... | Miller Robert E | Chief Financial Off ... | Buy | P | 4.86 | 5,000 | 24,300 | 6,714 | 1.7 K to 6.7 K (+291.72 %) |
Dec 02 2016 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 4.81 | 50,000 | 240,500 | 110,866 | |
Dec 02 2016 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Grant | A | 0.00 | 15,593 | 0 | 15,964 | 371 to 16 K (+4,202.96 %) |
Aug 25 2015 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 1.16 | 40,000 | 46,400 | 308,041 | |
Mar 06 2014 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 3.90 | 130,105 | 507,410 | 247,435 | |
Sep 20 2013 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 2.97 | 26,756 | 79,465 | 117,330 | |
Aug 27 2012 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 0.93 | 150,000 | 139,500 | 852,064 | |
Mar 09 2012 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 1.25 | 62,500 | 78,125 | 702,064 | |
Jun 17 2011 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 1.60 | 175,000 | 280,000 | 639,564 | |
Apr 01 2011 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 2.01 | 12,500 | 25,125 | 464,564 | |
Jun 09 2010 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 1.97 | 187,500 | 369,375 | 452,064 | |
Jun 09 2010 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | E | 3.00 | 30,000 | 90,000 | 264,564 | |
Nov 12 2009 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Buy | P | 1.65 | 2,000 | 3,300 | 73,000 | 71 K to 73 K (+2.82 %) |
Nov 12 2009 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Buy | P | 1.65 | 2,000 | 3,300 | 71,000 | 69 K to 71 K (+2.90 %) |
Nov 12 2009 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Buy | P | 1.70 | 1,800 | 3,060 | 69,000 | 67.2 K to 69 K (+2.68 %) |
Nov 12 2009 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Buy | P | 1.70 | 200 | 340 | 67,200 | 67 K to 67.2 K (+0.30 %) |
Nov 12 2009 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Buy | P | 1.70 | 900 | 1,530 | 67,000 | 66.1 K to 67 K (+1.36 %) |
Nov 12 2009 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Buy | P | 1.70 | 1,800 | 3,060 | 66,100 | 64.3 K to 66.1 K (+2.80 %) |
Nov 12 2009 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Buy | P | 1.70 | 300 | 510 | 64,300 | 64 K to 64.3 K (+0.47 %) |
Nov 12 2009 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Buy | P | 1.70 | 2,000 | 3,400 | 64,000 | 62 K to 64 K (+3.23 %) |
Nov 12 2009 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Buy | P | 1.67 | 2,000 | 3,340 | 62,000 | 60 K to 62 K (+3.33 %) |
Jan 30 2007 | OCLS | Oculus Innovative ... | Miller Robert E | Chief Financial Off ... | Option Exercise | A | 3.00 | 60,000 | 180,000 | 60,000 |
Page: 1